Research on Body Voice AI Recognition System for Children's Health Management

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine

About this trial

The purpose of this research is to develop a body voice artificial intelligence (AI) recognition device, also referred to as an AI-assisted body sound identification device, by utilizing a deep learning-based novel AI algorithm in conjunction with a big body voice model. It could identify normal and abnormal heart, breath, and bowel sounds, and to provide early screening and auxiliary diagnosis of congenital heart disease (CHD), respiratory infections, diarrhea and other common multi-occurring diseases.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 0~18 years old, gender is not limited

Children who have been diagnosed with congenital heart disease by cardiac ultrasound or who do not have congenital heart disease

Children diagnosed with bronchopneumonia or without bronchopneumonia

Children who are clinically diagnosed with intestinal diseases or who do not suffer from intestinal diseases

Disqualifiers

≥ 18 years old

Children who are unable to undergo cardiac ultrasound, chest imaging or other related examinations

Subjects who are unable to obtain informed consent, or who are unwilling to cooperate with the provision of diagnosis and treatment related data for further analysis and research as required by the study.

Trial population

1. Children (0-18 years old) with congenital heart disease confirmed by cardiac ultrasound and children without congenital heart disease confirmed by cardiac ultrasound. 2. Children (0-18 years old) with bronchopneumonia confirmed by chest imaging examination and children without bronchopneumonia confirmed by imaging. 3. Children (0-18 years old) with abdominal imaging confirmed abdominal disease and children diagnosed without abdominal disease by imaging.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Heart Auscultation and Echocardiography

    Diagnostic test

    Heart auscultation will be done by pediatrician and echocardiography by echocardiologist

  • Chest Auscultation and Chest imaging examinations

    Diagnostic test

    Chest auscultation will be done by pediatrician and chest imaging examinations by radiologist

  • Abdominal Auscultation and Abdominal imaging examinations

    Diagnostic test

    Abdominal auscultation will be done by pediatrician and chest imaging examinations by radiologist

Treatment groups

30,000 Participants
are divided into 1 treatment group
Group A: 0 ~ 18 years old children3 interventions

Trial outcomes

Primary outcomes

1

Sensitivity

Sensitivity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation

Time frame
1 month
2

Specificity

Specificity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation

Time frame
1 month
3

AUC

AUC in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation

Time frame
1 month

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.